27
Views
2
CrossRef citations to date
0
Altmetric
CASE REPORT

Successful treatment of reactive hemophagocytic syndrome by plasmapheresis and high-dose γ-globulin in a patient with systemic lupus erythematosus

, , , &
Pages 263-266 | Received 24 Dec 1999, Accepted 28 Jun 2000, Published online: 02 Jan 2014

References

  • Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Haematol 1997;66:135–51.
  • Yokota S, Nakajima S, Miyamae T, Itoh S, Imagawa T, Mori M. Macrophage activation syndrome (in Japanese). Ftinsho Ryumachi 2000;12:3–14.
  • Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemo-phagocytic syndrome. Am J Pediatr Hematol Oncol 1993;15:92–8.
  • Wong KF, Hui PK, Chan YW, Ha SY. The acute lupus hemo-phagocytic syndrome. Ann Intern Med 1991;114:387–90.
  • Okano M, Gross TG. Epstein-Barr virus-associated hemoph-agocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996;53:111–15.
  • Close P, Friedman D, Uri A. Viral-associated hemophagocytic syndrome. Med Pediatr Oncol 1990;18:119–22.
  • Takahashi K, Kumakura S, Ishikura H, Murakawa Y, Yamauchi Y, Kobayashi S. Reactive hemophagocytosis in systemic lupus erythematosus. Intern Med 1998;37:550–3.
  • Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y, Sekita T, et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 1997;59:247–53.
  • Lay JD, Tsao CJ, Chen JY, Kadin ME, Su U. Upregulation of tumor necrosis factor-a gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997; 100:1969–79.
  • Omagari K, Ashida R, Oh-I H, Minamino Y, Sasaki O, Ozono Y, et al. Successful treatment with cyclosporine in a case of hemophagocytic syndrome manifesting as severe liver dysfunction. Am J Med Sci 1997;314:403–7.
  • Tsuda H, Shirono K. Successful treatment of virus-associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor. Br J Haematol 1996; 93:572–5.
  • Takahashi T, Yagasaki F, Endo K, Takahashi M, Itoh Y, Kawai N, et al. Therapy-related AML after successful chemotherapy with low dose etoposide for virus-associated hemophagocytic syn-drome. Int J Hematol 1998;68:333–6.
  • Lemasters JL, Nieminen A-L, Qian T, et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochem Biophys Acta 1998; 1366:177–96.
  • Freeman Brathre MH, Sal- E, Joyce MJ, Pitel P. Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. J Pediatr 1993;123:479–81.
  • Gill DS, Spencer A, Cobcroft RG. High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome. Br J Haematol 1994;88:204–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.